The intricate interplay between SARS-CoV-2 and angiotensin-converting enzyme 2 (ACE2) receptors, triggering hypercoagulability and thrombophilia, elucidates the heightened risk of acute ischemic stroke [6]. This evidence concerns the gene ACE2 and thrombophilia.